Ticker
MRKRCompany Name
MARKER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 16.17M | $ 14.9M | $ 0 | -92.11% |
3/31/2025 | $ 12.79M | $ 14.94M | $ 0 | -116.87% |
12/31/2024 | $ 13.17M | $ 14.99M | $ 0 | -113.81% |
9/30/2024 | $ 31.23M | $ 100.54K | $ 0 | -0.32% |
6/30/2024 | $ 30M | $ 578.11K | $ 0 | -1.93% |
3/31/2024 | $ 37.19M | $ 534.24K | $ 0 | -1.44% |
12/31/2023 | $ 38.46M | $ 1.11M | $ 0 | -2.87% |
9/30/2023 | $ 26.49M | $ 1.24M | $ 0 | -4.68% |
6/30/2023 | $ 41.05M | $ 759.27K | $ 0 | -1.85% |
3/31/2023 | $ 12.05M | $ 822.1K | $ 0 | -6.82% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for MARKER THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 2.74M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 71.56M ]
(=) Payout Yield [ -3.82% ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |